Find Reports

Select Report Type

Learn More about Reports

Reimbursement Review

Export to CSV
Displaying 301 - 325 of 1430
Please scroll or swipe to view the full content.
Title Brand Name Generic Name Files Therapeutic Area Recommendation Type Status Submission Date Recommendation Date Project Number
inclisiranOpens in new tab Leqvio inclisiran
Response to the Procedural Review Panel’s Memorandum Report on the Procedural R…Opens in new tabMemorandum report to CADTHOpens in new tabRecommendation and ReasonsOpens in new tabClinical and Pharmacoeconomic combined ReportOpens in new tabPatient Group Input SubmissionOpens in new tabClinician InputOpens in new tabStakeholder feedback on Draft RecommendationOpens in new tab
 Primary hypercholesterolemia Do not reimburse Complete SR0681-000
Adult Classical Hodgkin Lympho...Opens in new tab
Final ReportOpens in new tab
 Adult Classical Hodgkin Lymphoma Complete PH0007-000
isatuximabOpens in new tab Sarclisa isatuximab
Recommendation and ReasonsOpens in new tabClinical and Pharmacoeconomic combined ReportOpens in new tabPatient Group Input SubmissionsOpens in new tabStakeholder feedback on Draft RecommendationOpens in new tab
 Multiple myeloma Reimburse with clinical criteria and/or conditions Complete PC0256-000
daratumumabOpens in new tab Darzalex daratumumab
Recommendation and ReasonsOpens in new tabClinical and Pharmacoeconomic combined ReportOpens in new tabPatient Group Input SubmissionsOpens in new tabClinician InputOpens in new tabStakeholder feedback on Draft RecommendationOpens in new tab
 Light chain (AL) amyloidosis Reimburse with clinical criteria and/or conditions Complete PC0257-000
sacituzumab govitecanOpens in new tab Trodelvy sacituzumab govitecan
Recommendation and ReasonsOpens in new tabClinical and Pharmacoeconomic combined ReportOpens in new tabPatient Group Input SubmissionsOpens in new tab
 Locally advanced or metastatic triple-negative breast cancer Reimburse with clinical criteria and/or conditions Complete PC0254-000
nivolumabOpens in new tab Opdivo nivolumab
Recommendation and ReasonsOpens in new tabClinical and Pharmacoeconomic combined ReportOpens in new tab
 Esophageal or gastroesophageal junction cancer Reimburse with clinical criteria and/or conditions Complete PC0253-000
alpelisibOpens in new tab Piqray alpelisib
Recommendation and ReasonsOpens in new tabClinical and Pharmacoeconomic combined ReportOpens in new tabPatient Group Input SubmissionsOpens in new tabClinician InputOpens in new tabStakeholder feedback on Draft RecommendationOpens in new tab
 Advanced or Metastatic Breast Cancer Do not reimburse Complete PC0247-000
pertuzumabOpens in new tab Perjeta pertuzumab
Recommendation and ReasonsOpens in new tabClinical and Pharmacoeconomic combined ReportOpens in new tabPatient Group Input SubmissionsOpens in new tabClinician InputOpens in new tabStakeholder feedback on Draft RecommendationOpens in new tab
 Early stage breast cancer Do not reimburse Complete PC0241-000
mecaserminOpens in new tab Increlex mecasermin
Recommendation and ReasonsOpens in new tabClinical and Pharmacoeconomic combined ReportOpens in new tabPatient Group Input SubmissionsOpens in new tabStakeholder feedback on Draft RecommendationOpens in new tab
 Severe primary insulin-like growth factor-1 deficiency Reimburse with clinical criteria and/or conditions Complete SR0692-000
triheptanoinOpens in new tab Dojolvi triheptanoin
Recommendation and ReasonsOpens in new tabClinical and Pharmacoeconomic combined ReportOpens in new tabPatient Group Input SubmissionsOpens in new tabClinician InputOpens in new tabStakeholder feedback on Draft RecommendationOpens in new tab
 Long-chain fatty acid oxidation disorders Reimburse with clinical criteria and/or conditions Complete SR0684-000
estradiolOpens in new tab Imvexxy estradiol
Recommendation and ReasonsOpens in new tabClinical and Pharmacoeconomic combined ReportOpens in new tabStakeholder feedback on Draft RecommendationOpens in new tab
 Dyspareunia Reimburse with clinical criteria and/or conditions Complete SR0694-000
osimertinibOpens in new tab Tagrisso osimertinib
Recommendation and ReasonsOpens in new tabClinical and Pharmacoeconomic combined ReportOpens in new tabPatient Group Input SubmissionOpens in new tabClinician InputOpens in new tabStakeholder feedback on Draft RecommendationOpens in new tab
 Non-small cell lung cancer Reimburse with clinical criteria and/or conditions Complete PC0246-000
enfortumab vedotinOpens in new tab Padcev enfortumab vedotin
Recommendation and ReasonsOpens in new tabClinical and Pharmacoeconomic combined ReportOpens in new tabPatient Group Input SubmissionsOpens in new tabStakeholder feedback on Draft RecommendationOpens in new tab
 Locally advanced or metastatic urothelial carcinoma Reimburse with clinical criteria and/or conditions Complete PC0251-000
zanubrutinibOpens in new tab Brukinsa zanubrutinib
Recommendation and ReasonsOpens in new tabClinical and Pharmacoeconomic combined ReportOpens in new tabPatient Group Input SubmissionOpens in new tabClinician InputOpens in new tabStakeholder feedback on Draft RecommendationOpens in new tab
 Waldenström’s macroglobulinemia Reimburse with clinical criteria and/or conditions Complete PC0248-000
pembrolizumabOpens in new tab Keytruda pembrolizumab
Recommendation and ReasonsOpens in new tabClinical and Pharmacoeconomic combined ReportOpens in new tabPatient Group Input SubmissionsOpens in new tabClinician InputOpens in new tabStakeholder feedback on Draft RecommendationOpens in new tab
 Esophageal carcinoma, gastroesophageal junction adenocarcinoma Reimburse with clinical criteria and/or conditions Complete PC0250-000
galcanezumabOpens in new tab Emgality galcanezumab
Recommendation and ReasonsOpens in new tabClinical and Pharmacoeconomic combined ReportOpens in new tabPatient Group Input SubmissionsOpens in new tabStakeholder feedback on Draft RecommendationOpens in new tab
 Prevention of migraine Reimburse with clinical criteria and/or conditions Complete SR0693-000
macitentan and tadalafilOpens in new tab Opsynvi macitentan and tadalafil
Recommendation and ReasonsOpens in new tabClinical and Pharmacoeconomic combined ReportOpens in new tabStakeholder Feedback on Draft RecommendationOpens in new tab
 Pulmonary arterial hypertension Reimburse with clinical criteria and/or conditions Complete SR0690-000
luspaterceptOpens in new tab Reblozyl luspatercept
Recommendation and ReasonsOpens in new tabClinical and Pharmacoeconomic combined ReportOpens in new tabPatient Group Input SubmissionsOpens in new tabClinician InputOpens in new tabStakeholder feedback on Draft RecommendationOpens in new tab
 Myelodysplastic syndromes-associated anemia Reimburse with clinical criteria and/or conditions Complete SR0670-000
chlormethine hydrochlorideOpens in new tab Ledaga chlormethine hydrochloride
Recommendation and ReasonsOpens in new tabClinical and Pharmacoeconomic combined ReportOpens in new tabPatient Group Input SubmissionOpens in new tabClinician InputOpens in new tabStakeholder feedback on Draft RecommendationOpens in new tab
 T-cell lymphoma Do not reimburse Complete PC0242-000
tucatinibOpens in new tab Tukysa tucatinib
Recommendation and ReasonsOpens in new tabClinical and Pharmacoeconomic combined ReportOpens in new tabPatient Group Input SubmissionOpens in new tabClinician InputOpens in new tabStakeholder feedback on Draft RecommendationOpens in new tab
 Advanced or Metastatic Breast Cancer Reimburse with clinical criteria and/or conditions Complete PC0243-000
idecabtagene vicleucelOpens in new tab Abecma idecabtagene vicleucel
Recommendation and ReasonsOpens in new tabClinical, Pharmacoeconomic, and Ethics combined ReportOpens in new tabPatient Group Input SubmissionsOpens in new tabClinician InputOpens in new tabStakeholder feedback on Draft RecommendationOpens in new tab
 Multiple myeloma Do not reimburse Complete PG0240-000
Colorectal CancerOpens in new tab
Final ReportOpens in new tab
 Colorectal Cancer Complete PH0005-000
Trientine HydrochlorideOpens in new tab MAR-Trientine Trientine Hydrochloride
Recommendation and ReasonsOpens in new tabClinical and Pharmacoeconomic combined ReportOpens in new tabStakeholder feedback on Draft RecommendationOpens in new tab
 Wilson's Disease Reimburse with clinical criteria and/or conditions Complete SR0680-000
romosozumabOpens in new tab Evenity romosozumab
Recommendation and ReasonsOpens in new tabClinical and Pharmacoeconomic combined ReportOpens in new tabPatient Group Input SubmissionsOpens in new tabStakeholder feedback on Draft RecommendationOpens in new tab
 Osteoporosis, postmenopausal women Reimburse with clinical criteria and/or conditions Complete SR0676-000
pembrolizumabOpens in new tab Keytruda pembrolizumab
Recommendation and ReasonsOpens in new tabClinical and Pharmacoeconomic combined ReportOpens in new tabPatient Group Input SubmissionOpens in new tabClinician InputOpens in new tabStakeholder feedback on Draft RecommendationOpens in new tab
 Classical Hodgkin lymphoma Reimburse with clinical criteria and/or conditions Complete PC0236-000

Health Technology Review

Last Updated
Export to CSV
Displaying 301 - 325 of 602
Please scroll or swipe to view the full content.
Title Description Files Last Updated Project Sub Line Status Project Number
Radioiodine Resensitization for Radioiodine Refractory Metastatic Differentiated Thyroid CancerOpens in new tab
Radioiodine Resensitization for Radioiodine Refractory Metastatic Differentiate…Opens in new tab
 Rapid Review Completed RC1419-000
Ketamine for Adults With Treatment-Resistant Depression or Post-Traumatic Stress DisorderOpens in new tab
Ketamine for Adults With Treatment-Resistant Depression or Post-Traumatic Stress Disorder Opens in new tab
Rapid Review Completed RC1420-000
Risk Factors and Preventive Interventions for Post‒COVID-19 conditionOpens in new tab
Systematic Review Complete RE0039-000
Metered-Dose Inhalers for Medical Cannabis UseOpens in new tab
Metered-Dose Inhalers for Medical Cannabis UseOpens in new tab
 Rapid Review Completed RC1417-000
Robotic-Assisted Surgical Systems for Hip ArthroplastyOpens in new tab
Robotic-Assisted Surgical Systems for Hip ArthroplastyOpens in new tab
 Rapid Review Completed RC1412-000
Therapeutic Mattresses for Chronic PainOpens in new tab
Therapeutic Mattresses for Chronic PainOpens in new tab
 Rapid Review Completed RC1415-000
Dementia Concerns and Considerations: Our Panel of People With Lived ExperienceOpens in new tab
Dementia Concerns and Considerations: Our Panel of People With Lived ExperienceOpens in new tab
 Technology Review Completed EH0107-000 - HC0022-000
Intraocular Lenses for Infants with AphakiaOpens in new tab
Intraocular Lenses for Infants With Aphakia - Health Technology ReviewOpens in new tabIntraocular Lenses for Infants With Aphakia - Project Protocol (Amended Report)Opens in new tabIntraocular Lenses for Infants With Aphakia - Project Protocol (Superseded Repo…Opens in new tabIn Brief: Intraocular Lenses for Infants With AphakiaOpens in new tab
 Systematic Review Complete RE0036-000
Folate Testing in People With Suspected Folate DeficiencyOpens in new tab
Folate Testing in People With Suspected Folate DeficiencyOpens in new tab
 Rapid Review Completed RC1414-000
Vitamin B12 Testing in People with Suspected Vitamin B12 DeficiencyOpens in new tab
Vitamin B12 Testing in People with Suspected Vitamin B12 DeficiencyOpens in new tab
 Rapid Review Completed RC1413-000
Adalimumab for the Treatment of Pediatric Populations With Non-Infectious UveitisOpens in new tab
Adalimumab for the Treatment of Pediatric Populations With Non-Infectious Uveit…Opens in new tab
 Rapid Review Completed RD0064-000
Robotic-Assisted Surgical Systems for Knee ArthroplastyOpens in new tab
Robotic-Assisted Surgical Systems for Knee ArthroplastyOpens in new tab
 Rapid Review Completed RC1411-000
Custom-Made Foot Orthotics for People with Lower Limb ConditionsOpens in new tab
Custom-Made Foot Orthotics for People with Lower Limb ConditionsOpens in new tab
 Rapid Review Completed RC1410-000
Anakinra Therapy for Hemophagocytic LymphohistiocytosisOpens in new tab
Anakinra Therapy for Hemophagocytic LymphohistiocytosisOpens in new tab
 Rapid Review Completed RC1409-000
Temperature Management in Patients Post-Cardiac ArrestOpens in new tab
Temperature Management in Patients Post-Cardiac ArrestOpens in new tab
 Rapid Review Completed RC1407-000
Antibiotic Solutions for Surgical IrrigationOpens in new tab
Antibiotic Solutions for Surgical IrrigationOpens in new tab
 Rapid Review RC1408-000
Nirmatrelvir and Ritonavir (Paxlovid) for Mild to Moderate COVID-19Opens in new tab
Nirmatrelvir and Ritonavir (Paxlovid) for Mild to Moderate COVID-19Opens in new tab
 Technology Review Completed HD0007-000
Adalimumab for the Treatment of Adults With Non-Infectious UveitisOpens in new tab
Adalimumab for the Treatment of Adults With Non-Infectious UveitisOpens in new tab
 Rapid Review Completed RD0063-000
Orthopedic Footwear for People With Lower-Limb ConditionsOpens in new tab
Orthopedic Footwear for People With Lower-Limb ConditionsOpens in new tab
 Rapid Review Completed RC1406-000
The Small House Model for Long-Term CareOpens in new tab
The Small House Model for Long-Term CareOpens in new tabIn Brief: The Small House Model to Support Older Adults in Long-Term CareOpens in new tab
 Environmental Scan Completed ES0359-000
Pharmacogenomic Testing in Depression: A 2021 UpdateOpens in new tab
Pharmacogenomic Testing in Depression: A 2021 UpdateOpens in new tab
 Rapid Review Completed RC1403-000
Evaluations of Virtual CareOpens in new tab
Evaluations of Virtual CareOpens in new tab
 Environmental Scan Complete ES0358-000
Lenalidomide, Bortezomib, and Dexamethasone as Induction Therapy Prior to Autologous Stem Cell Transplant for Multiple MyelomaOpens in new tab
Lenalidomide, Bortezomib, and Dexamethasone as Induction Therapy Prior to Autol…Opens in new tab
 Rapid Review Completed RC1404-000
Floatation Therapy for Physical ConditionsOpens in new tab
Floatation Therapy for Physical ConditionsOpens in new tab
 Rapid Review Completed RC1398-000
Clinical Effectiveness of Opioid Substitution TreatmentOpens in new tab
Clinical Effectiveness of Opioid Substitution TreatmentOpens in new tab
 Rapid Review Completed RC1405-000 - RB1604-000

Horizon Scan

Last Updated
Export to CSV
Displaying 101 - 110 of 110

Projects in Progress

Last Updated
Export to CSV
Displaying 1 - 25 of 25

View All Reports

Last Updated
Export to CSV
Displaying 301 - 325 of 2142
Please scroll or swipe to view the full content.
Title Description Files Last Updated Project Line Project Sub Line Status Project Number
Utilization of Long-Acting Injectable Antipsychotics Opens in new tab
Health Technology Review Technology Review In Progress HC0098-000
Pharmaceutical Reviews Update — Issue 52 Opens in new tab
Reimbursement Review Pharmaceutical Review Update
epcoritamabOpens in new tab
Recommendation and ReasonsOpens in new tabPatient and Clinician Group inputOpens in new tabClinical and Pharmacoeconomic Combined ReportOpens in new tabFeedback on Draft RecommendationOpens in new tab
 Reimbursement Review Complete PC0334-000
everolimusOpens in new tab
Recommendation and ReasonsOpens in new tabClinical and Pharmacoeconomic Combined ReportOpens in new tabResponses to Questions From the Drug ProgramsOpens in new tabStakeholder InputOpens in new tab
 Reimbursement Review Complete SX0814-000
eltrombopagOpens in new tab
Recommendation and ReasonsOpens in new tabResponses to Questions From the Drug ProgramsOpens in new tabClinical and Pharmacoeconomic Combined ReportOpens in new tabStakeholder InputOpens in new tabStakeholder Feedback on Draft RecommendationOpens in new tab
 Reimbursement Review Complete SX0777-000
rivaroxabanOpens in new tab
Recommendation and ReasonOpens in new tabResponses to Questions From the Drug ProgramsOpens in new tabClinical and Pharmacoeconomic Combined ReportOpens in new tabStakeholder Input Opens in new tabStakeholder Feedback on Draft RecommendationOpens in new tab
 Reimbursement Review Complete SX0750-000 - SR0750-000
nab-paclitaxelOpens in new tab
Recommendation and ReasonsOpens in new tabResponses to Questions From the Drug ProgramsOpens in new tabClinical and Pharmacoeconomic Combined ReportOpens in new tabPatient and Clinician Group InputOpens in new tabFeedback on Draft RecommendationOpens in new tab
 Reimbursement Review Complete PX0360-000
Nab-paclitaxelOpens in new tab
Recommendation and ReasonsOpens in new tabResponses to Questions From the Drug ProgramsOpens in new tabClinical and Pharmacoeconomic Combined ReportOpens in new tabPatient and Clinician Group InputOpens in new tabFeedback on Draft RecommendationOpens in new tab
 Reimbursement Review Complete PX0354-000
PembrolizumabOpens in new tab
Recommendation and Reason Opens in new tabResponses to Questions From the Drug ProgramsOpens in new tabClinical and Pharmacoeconomic Combined ReportOpens in new tabStakeholder InputOpens in new tab
 Reimbursement Review Complete PX0346-000
Nivolumab and Ipilimumab Opens in new tab
Recommendation and ReasonsOpens in new tabResponses to Questions From the Drug ProgramsOpens in new tabClinical and Pharmacoeconomic combined ReportOpens in new tabStakeholder InputOpens in new tab
 Reimbursement Review Complete PX0347-000
Nab-paclitaxelOpens in new tab
Recommendation and reasonsOpens in new tabResponses to Questions From the Drug ProgramsOpens in new tabClinical and Pharmacoeconomic Combined ReportOpens in new tabPatient and Clinician Group InputOpens in new tab
 Reimbursement Review Complete PX0348-000
bevacizumab and lomustineOpens in new tab
Recommendation and ReasonsOpens in new tabResponses to Questions From the Drug ProgramsOpens in new tabClinical and Pharmacoeconomic Combined ReportOpens in new tabStakeholder Input - CliniciansOpens in new tabStakeholder Input - IndustryOpens in new tabStakeholder Feedback on Draft RecommendationOpens in new tab
 Reimbursement Review Complete PX0318-000
Review of Guidelines on Bupropion for DepressionOpens in new tab
Review of Guidelines on Bupropion for Depression Opens in new tab
Health Technology Review Rapid Review Completed RC1558-000
GLP-1 Receptor Agonists and Self-Harm Opens in new tab
Health Technology Review Observational Study Active OS0009-000
relugolixOpens in new tab
Recommendation and Reason Opens in new tabClinical and Pharmacoeconomic Combined ReportOpens in new tabStakeholder feedback on Draft RecommendationOpens in new tabPatient and Clinician Group inputOpens in new tab
 Reimbursement Review Complete PC0342-000
Gabapentin for SeizuresOpens in new tab
Gabapentin for Seizures Opens in new tab
Health Technology Review Rapid Review Completed RC1557-000
Early Biologic Treatment for Inflammatory Bowel DiseaseOpens in new tab
Early Biologic Treatment for Inflammatory Bowel Disease Opens in new tab
Health Technology Review Rapid Review Completed RC1552-000
The Utilization of PCSK9 Inhibitors in Familial Hypercholesterolemia Opens in new tab
Health Technology Review Technology Review Active HC0094-000
Airway Management in Out-of-Hospital EmergenciesOpens in new tab
Airway Management in Out-of-Hospital Emergencies Opens in new tab
Health Technology Review Rapid Review Completed RC1555-000
CRISPR Technologies for In Vivo and Ex Vivo Gene EditingOpens in new tab Our Horizon Scan provides an overview of CRISPR technologies and their current and potential roles in health care.
Final ReportOpens in new tab
 Horizon Scan Emerging Health Technologies Completed EH00127-000 - HC0092-000
BRAF and MEK Inhibitors for Active or Symptomatic Melanoma Brain MetastasisOpens in new tab
BRAF and MEK Inhibitors for Active or Symptomatic Melanoma Brain Metastasis Opens in new tab
Health Technology Review Rapid Review Completed RC1549-000
datopotamab deruxtecanOpens in new tab
Reimbursement Review Cancelled PC0384-000
Re-treatment With Immune Checkpoint Inhibitors: Utilization AnalysisOpens in new tab
Health Technology Review Technology Review In Progress HC0093-000
bimekizumab Opens in new tab
Recommendation and ReasonsOpens in new tabClinical and Pharmacoeconomic Combined ReportOpens in new tabFeedback on Draft RecommendationOpens in new tabPatient and Clinician Group inputOpens in new tab
 Reimbursement Review Complete SR0809-000
leniolisib Opens in new tab
Reimbursement Review Suspended SR0792-000

Provisional Funding Algorithm

Export to CSV
Displaying 76 - 81 of 81